T cells
-
How to translate discoveries into treatments fast
Ensuring patients receive the benefits of ground-breaking basic science discoveries as quickly as possible requires intellectual and technological collaboration. The latest hot topic in immuno-oncology – following checkpoint inhibitors – is CAR-T cell therapy. It went from the very first research publication in 1989, through development and into clinic in under 20 years. Mario Assenmacher,...
-
Checkpoint inhibitory receptors keep the immune system in check
Pictured: Professor Andreas Radbruch, President of the European Federation of Immunological Societies (EFIS) This is an opinion piece and the source has had no input to any other content in this campaign Cancer checkpoint blockade – this year’s Day of Immunology theme – has revolutionised cancer treatment for many patients. Every year on April 29th,...
Health Awareness
